Growth Competition in Interspecies Chimeras: A New Paradigm for Blastocyst Complementation

Emily B Ballard1, Jun Wu2

  • 1Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Cell Stem Cell
|January 8, 2021
PubMed

Insights

Researchers enhanced interspecies organogenesis using blastocyst complementation. By disabling the insulin-like growth factor 1 receptor (Igf1r) in host embryos, they improved donor cell contribution and chimerism for developmental biology research.

Area of Science:

  • Developmental Biology
  • Regenerative Medicine
  • Genetics

Background:

  • Blastocyst complementation is key for interspecies organogenesis.
  • Low chimerism due to developmental incompatibilities limits its effectiveness.

Purpose of the Study:

  • To overcome developmental barriers in interspecies blastocyst complementation.
  • To enhance donor cell contribution and chimerism.

Main Methods:

  • Disabling the insulin-like growth factor 1 receptor (Igf1r) in host embryos.
  • Utilizing blastocyst complementation for interspecies organogenesis.

Main Results:

  • The disabling of Igf1r conferred a growth advantage to donor cells.
  • Improved chimerism was observed from mid-gestation onward.

Conclusions:

  • Targeting Igf1r signaling can overcome early developmental incompatibilities.
  • This strategy enhances the potential of blastocyst complementation for organogenesis research.